Investigating the mechanism of novel mediator of decitabine response methylenetetrahydrofolate dehydrogenase 2 in breast cancer
Investigating the mechanism of novel mediator of decitabine response methylenetetrahydrofolate dehydrogenase 2 in breast cancer
研究乳腺癌地西他滨反应新介质亚甲基四氢叶酸脱氢酶2的机制
批准号：
428926
负责人：
Kvas Maia A
金额：
$1.27万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-12-01 至 2020-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"Like all other anti-cancer drugs, a new drug called decitabine will only work for some patients. Cancer cells can turn genes on or off by changing the methylation of DNA. Decitabine is a drug that decreases DNA methylation. In some cancers, treatment wit
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
